
Why Class III NHP Applications Can Take Over a Year and How to Plan Your Launch
If you are planning a Class III NHP application, understanding the full scope of Health Canada’s review process is the

If you are planning a Class III NHP application, understanding the full scope of Health Canada’s review process is the

Livestock feed registration in Canada is overseen by the Canadian Food Inspection Agency (CFIA), which administers the Feeds Act and

Many aesthetic devices sold in Canada meet the definition of a medical device under the Food and Drugs Act, because

Caffeine pouches in Canada, also sold as energy pouches or nicotine free pouches, sit between the lip and gum and

Understanding what medical device testing Health Canada expects before you submit your licence application is one of the most consequential

Animal feed ingredient approval in Canada is not as straightforward as it might seem when you first look at the

Getting an NPN for a women’s health supplement is a key step before your product can be sold in Canada.

GLP-1 claims on natural health products are appearing more frequently as consumer interest in metabolic health and weight management continues

Animal ingredient approval in the U.S. starts with one decision: which regulatory pathway fits your ingredient. Making that choice before

Securing an NPN for berberine is one of the most strategically important steps you can take before bringing this high-demand

QMSR represents one of the most significant shifts in U.S. medical device regulation in decades. The Quality Management System Regulation,

Securing an NPN for NAD supplements is one of the most pressing regulatory milestones your team will face when bringing

If your company manufactures, processes, or distributes food, drugs, or medical devices in the United States, FDA registration renewal is

Do you sell, or plan to sell, beauty devices on Amazon Canada? Class II licensing and MDSAP (Medical Device Single

When your company prepares to bring a new food ingredient into the U.S. market, a dietary exposure assessment is one

Structure/function claims for dietary supplements and conventional foods look deceptively similar on the surface, but the two frameworks that govern

Choosing Between a Food Additive Petition and GRAS Notification Bringing a new ingredient to the U.S. food market means choosing

Petitioning FDA for a new color additive is a detailed, document-heavy process, and understanding the requirements before you begin makes

MDEL licence cancellation is one of the more disruptive regulatory outcomes a medical device company can face in Canada. It stops your

Selling a dietary supplement on TikTok Shop sounds like a straightforward channel expansion, until your product listing gets rejected without

For pet health companies planning to sell vitamins, minerals, botanicals, or other supplement-style products for companion animals in Canada, VHP

FSVP compliance is one of the most overlooked requirements for companies exporting food, dietary supplements, and ingredient products into the

Confirming that your laser hair removal device is Health Canada compliant is an essential step before entering the Canadian market.

The U.S. Food and Drug Administration (FDA) requires most registered food facilities to renew their registration every two years, and

Introduction Canada legalized recreational cannabis in 2018. However, the rules for cannabis consumption lounges are still limited. These lounges allow

Few things set back a product launch more painfully than a rejection letter from the FDA. When your 510(k) submission

Pursuing GRAS status for an extract is not the same as pursuing it for a whole botanical or a well-characterised food ingredient. The

Sea moss has gone from niche wellness ingredient to mainstream market opportunity, and businesses across North America are taking notice. If you are

Software that diagnoses, monitors, or treats a health condition carries a different kind of regulatory weight than a physical device. If

Toothpaste sounds simple. It sits on store shelves next to shampoo and soap, and most consumers never think twice about

The question of whole ingredient vs extract GRAS requirements comes up constantly when companies formulate with botanicals, functional ingredients, or

When you submit a product licence application for a natural health product in Canada, your submission does not enter a

Getting an FDA 510(k) submission right the first time is one of the most consequential steps in your medical device’s path to market.

Weight loss supplements are among the most commercially attractive categories in the dietary supplement industry and among the most closely

You have a protein product ready to bring to market in Canada, and classifying it correctly is holding up your

If you are bringing medical devices to the Canadian market, one of the first compliance questions to resolve is whether

Cannabis edibles are one of the most tightly regulated product categories in Canada — and one of the most commercially

Determining whether your product is a veterinary health product or drug in Canada is one of the first and most consequential decisions you

If you hold a cannabis licence in Canada, you’ve likely come across the acronyms GMP, GPP, and GACP. They’re not

If your organization sells finished medical devices in the United States, the structure of your medical device QMS is no

Standard operating procedures for cannabis retail business operations are not optional extras. They are foundational documents that provincial regulators expect

If you are preparing to launch a new ingredient or food product in Australia or New Zealand, one of the

Thinking about launching a new food ingredient in the U.S. often raises an important question: how do you demonstrate safety to the

If you manufacture or sell food ingredients in the United States, you have almost certainly come across the term GRAS. Yet many companies

Introduction When bringing a probiotic ingredient to the U.S. market, one of the first things to consider is its safety.

Bringing a new food ingredient to the European market often raises one critical question early in the process. Does the

Introduction Introduction Bringing a new dietary ingredient to the U.S. market involves more than product formulation and sourcing. If an

Companies introducing new food ingredients into the United States must demonstrate that those ingredients are safe under their intended conditions

Navigating the U.S. Food and Drug Administration (FDA) review process can be challenging for food and ingredient companies, especially when timelines do

Pet food companies are under growing pressure to ensure that every ingredient in their formulas meets safety expectations, and GRAS compliance

Introduction When working toward a GRAS conclusion for an ingredient, a common question is whether it is possible to combine

The difference between GRAS and FEMA GRAS is a common point of confusion for companies working with food and flavor ingredients. When

FDA GRAS projects can feel overwhelming, especially when you are trying to balance timelines, research needs, and budget pressures at

EFSA’s transparency rules for novel foods are reshaping how businesses approach regulatory compliance in the European Union. If you’re planning to introduce

Introducing a new food ingredient into the Australian or New Zealand market means working within a regulatory system that takes

Building your safety narrative for a GRAS notice begins with toxicological studies for GRAS conclusion, and this foundation is one of the

When it comes to importing human food and animal food into Canada, many businesses assume the process is similar. In

Getting an NPN for sports supplements is essential for businesses looking to market their products legally in Canada. The Natural

If your company manufactures, repacks, relabels, or imports drugs for distribution in the U.S., it’s time to prepare for the

When exporting food supplements to Canada, understanding trade agreements can make a huge difference in your profitability. The Comprehensive Economic

When it comes to ingredient safety, an expert panel plays one of the most critical roles in the GRAS (Generally

Getting GRAS status for an enzyme is one of the most important steps to ensure your ingredient is recognized as

Introduction: Why EFSA Novel Food Clinical Studies Matter Bringing a novel food to the European market requires more than innovation.

If you’re planning to introduce an innovative ingredient or food product in the European Union, understanding how to submit an

After years of uncertainty and legal disputes, the U.S. Food and Drug Administration (FDA) declared on September 29, 2025, that

Preparing Instructions for Use (IFUs) for FDA Submission for Medical Devices Preparing Instructions for Use for FDA submission can feel

When it comes to SR&ED eligibility, many businesses assume their projects do not qualify. This misconception often leads to missed

The Scientific Research and Experimental Development (SR&ED) program is one of Canada’s most valuable federal tax incentives for businesses. If

Reaching GRAS status is an important step if you want your Generally Recognized as Safe ingredient accepted for use in

Preparing a GRAS dossier is one of the most important steps when seeking FDA recognition for a new substance in

What is GMP training, and why does it matter? If your company makes, packages, labels, or imports health products, this

Planning to sell a medical device under your brand in Canada? You might assume that using a licensed manufacturer means

Over the past few weeks, many natural health product (NHP) companies have been caught off guard by an increase in

Why is CFIA Updating its Feed Regulations? The Canadian Food Inspection Agency (CFIA) is in the process of modernizing its

When preparing to launch a medical device in the U.S., one of the first and most important decisions you’ll make

If you work in the life sciences industry, you’ve likely heard of GMP, Good Manufacturing Practice. It’s a fundamental part

When it comes to audits related to Health Canada requirements, staying compliant is about more than checking off a list.

If you are planning to market animal health products, the question of pet supplements or veterinary health products will come

Thinking of selling hydration products in Canada? If your product makes a therapeutic claim, you may need a Natural Product

The FDA has confirmed that FY 2025 OMUFA facility fees are due soon. If your business was registered as a

When introducing a new substance into the market, one of the first questions you need to answer is whether it’s

Understanding the distinction between traditional cosmetics vs. cosmeceuticals is essential if you’re manufacturing or marketing skincare or beauty products in

If you’re importing food into Canada, one of the key roles you’ll need to understand is that of the SFCR

If you’re planning to sell or distribute a medical device in Canada, you’re going to hear two terms over and

If you’re finding it difficult to navigate the GRAS process, you’re not alone. Whether you’re introducing a new food ingredient

The eczema product market continues to grow as consumer demand increases, but that doesn’t mean you can jump in without

How FDA and Health Canada Regulate Cosmetics Differently Thinking about launching your cosmetic line in North America? Whether you’re a

Food additive submission may not be the flashiest part of launching a new food product in Canada, but it’s one

Selling cosmetics on Amazon Canada can open up a world of opportunity, but it comes with strict compliance expectations. Recently,

If you’re planning to launch a product like a protein bar, electrolyte drink, or mushroom supplement in Canada, it’s important

If you plan to sell a natural health product in Canada, you’ve probably asked what an NPN is and why

If you’re working in the medical device space and looking to expand into the Canadian market, here’s a question for

If you’re trying to bring a food or supplement product to both the Canadian and US markets, you’ve probably already

Submitting a medical device to the FDA can feel like navigating a maze. Even the most seasoned teams can overlook

As of March 12, 2025 Health Canada has implemented changes to the Cannabis Act and its Regulations. These changes may

The self-affirmed GRAS pathway may soon be eliminated. On March 10, 2025, HHS Secretary Robert F. Kennedy Jr. directed the

Health Canada is conducting a public consultation on CBD regulations for natural health products, exploring a pathway to allow non-prescription

GRAS in pet food – these four words can make a big difference in your product’s regulatory status. Understanding what

Bringing a new substance into Australia’s listed medicines market can be challenging. The TGA approval for new substances process involves

The introduction of Bill 96 in Quebec brings new challenges for businesses across Canada. As a result, this legislation emphasizes